PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 16 analysts with an average price target of $42.28. This is a potential upside of $8.51 (25.2%) from yesterday's end of day stock price of $33.77.

PTC Therapeutics's activity chart (see below) currently has 130 price targets and 203 ratings on display. The stock rating distribution of PTCT is 38.16% HOLD, 21.05% SELL and 40.79% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.86% with an average time for these price targets to be met of 151.08 days.

Highest price target for PTCT is $64, Lowest price target is $25, average price target is $42.28.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 04-Sep-2024. First documented stock forecast 14-Feb-2014.

Currently out of the existing stock ratings of PTCT, 29 are a HOLD (38.16%), 16 are a SELL (21.05%), 31 are a BUY (40.79%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$44

$10.01 (29.45%)

12 days ago

8/11 (72.73%)

$10.41 (30.99%)

205

Hold

$47

$13.01 (38.28%)

$47

21 days ago

3/6 (50%)

$12.09 (34.63%)

79

Buy

$64

$30.01 (88.29%)

$64

26 days ago

0/13 (0%)

$30.07 (88.62%)

Hold

$31

$-2.99 (-8.80%)

$25

1 months 7 days ago

8/12 (66.67%)

$-0.29 (-0.93%)

278

Hold

$32

$-1.99 (-5.85%)

$30

2 months 4 days ago

6/8 (75%)

$-1.27 (-3.82%)

53

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 151.08 days on average for the stock forecasts to be realized with a an average price target met ratio 46.86

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $30.01

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$21.99

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?